Matrix stiffness-regulated NSUN2 Increases HSP90AA1 expression to promote endoplasmic reticulum stress and hepatocellular carcinoma progression
Extracellular matrix (ECM) stiffness elevation, a prominent mechanical attribute in liver cirrhosis, is a key driver of hepatocellular carcinoma (HCC) progression. RNA 5-methylcytosine (m 5 C) modification regulates multiple RNA species to influence tumorigenesis, but its role in mechanotransduction—especially in response to matrix stiffness—remains unclear. Here, we found that increased matrix stiffness enhances HCC cell proliferation and metastasis, accompanied by elevated global m 5 C levels. High stiffness triggers autocrine transforming growth factor-β (TGF-β) secretion in HCC cells, which activates transcription factor Smad3 to upregulate NSUN2, a core m 5 C methyltransferase. Clinically, high NSUN2 expression and elevated m 5 C levels correlate with poor prognosis in HCC patients. Further studies showed NSUN2 directly binds to HSP90AA1 mRNA, enhances its m 5 C modification, and recruits the m 5 C reader ALYREF to stabilize HSP90AA1 mRNA. We also confirmed the matrix stiffness-NSUN2-HSP90AA1 axis activates endoplasmic reticulum (ER) stress, forming a pro-tumor cascade that promotes HCC growth and progression. Notably, we identified Vilanterol as a candidate NSUN2-targeting compound that effectively downregulates NSUN2 expression and global m 5 C levels and suppresses HCC malignant phenotypes. Collectively, our findings uncover a previously unrecognized regulatory axis, the matrix stiffness–NSUN2–HSP90AA1–ER stress axis, in HCC, and suggest that Vilanterol may serve as a promising therapeutic agent for HCC.
Authors
- 迟晓芹
- 尹震宇
- Chengrong Xie (ORCID: https://orcid.org/0000-0001-9296-4146)
- 王付强
- Changhong Luo (ORCID: https://orcid.org/0009-0001-9978-4815)
- Yiwei Peng (ORCID: https://orcid.org/0009-0001-2901-6458)
- Zhangquan Yang
- Yuyan Lu
- Xijun Chen
- Yingcan Wu
- Jing Wen
- Yijia Shen
- Lingyun Lin
- Yu Sun
- Jinzhu Wang
Institutions
- Beijing University of Chinese Medicine (CN)
- Xiamen University (CN)
- University Medical Center Utrecht (NL)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
- Zhongshan Hospital of Xiamen University (CN)
- First Hospital of Jiaxing (CN)
Publication Details
- Journal
- Experimental Hematology and Oncology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s40164-026-00867-0
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00